Bourgier C - Search Results

1

Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study.

Bachelot T, Bourgier C, Cropet C, Ray-Coquard I, Ferrero JM, Freyer G, Abadie-Lacourtoisie S, Eymard JC, Debled M, Spaëth D, Legouffe E, Allouache D, El Kouri C, Pujade-Lauraine E. Bachelot T, et al. Among authors: bourgier c. J Clin Oncol. 2012 Aug 1;30(22):2718-24. doi: 10.1200/JCO.2011.39.0708. Epub 2012 May 7. J Clin Oncol. 2012. PMID: 22565002 Clinical Trial.

2

Radiation-induced lymphocyte apoptosis assay: Primetime for routine clinical use?

Azria D, Michalet M, Riou O, Bourgier C, Brengues M, Sroussi Y, Gourgou S, Farcy-Jacquet MP, Kotzki L, Ozsahin M. Azria D, et al. Among authors: bourgier c. Cancer Radiother. 2024 Oct;28(5):442-448. doi: 10.1016/j.canrad.2024.06.002. Epub 2024 Sep 19. Cancer Radiother. 2024. PMID: 39304399 Free article. Review.

3

Phase II randomized study of whole-brain radiation therapy with or without concurrent temozolomide for brain metastases from breast cancer.

Cao KI, Lebas N, Gerber S, Levy C, Le Scodan R, Bourgier C, Pierga JY, Gobillion A, Savignoni A, Kirova YM. Cao KI, et al. Among authors: bourgier c. Ann Oncol. 2015 Jan;26(1):89-94. doi: 10.1093/annonc/mdu488. Epub 2014 Oct 29. Ann Oncol. 2015. PMID: 25355723 Free article. Clinical Trial.

4

Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial.

Bourgier C, Kerns S, Gourgou S, Lemanski C, Gutowski M, Fenoglietto P, Romieu G, Crompton N, Lacombe J, Pèlegrin A, Ozsahin M, Rosenstein B, Azria D. Bourgier C, et al. Ann Oncol. 2016 Mar;27(3):474-80. doi: 10.1093/annonc/mdv602. Epub 2015 Dec 17. Ann Oncol. 2016. PMID: 26681684 Free PMC article. Clinical Trial.

5

Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial (UCBG 0609).

Lerebours F, Rivera S, Mouret-Reynier MA, Alran S, Venat-Bouvet L, Kerbrat P, Salmon R, Becette V, Bourgier C, Cherel P, Boussion V, Balleyguier C, Thibault F, Lavau-Denes S, Nabholz JM, Sigal B, Trassard M, Mathieu MC, Martin AL, Lemonnier J, Mouret-Fourme E. Lerebours F, et al. Among authors: bourgier c. Cancer. 2016 Oct;122(19):3032-40. doi: 10.1002/cncr.30143. Epub 2016 Jun 17. Cancer. 2016. PMID: 27315583 Free article. Clinical Trial.

6

[Treatment of primary disease with irradiation in case of de novo metastatic breast cancer].

Ghannam Y, Bourgier C, Legouté F, Gonzalez-Moya A, Lizée T, Trémolières P, Hennequin C. Ghannam Y, et al. Among authors: bourgier c. Cancer Radiother. 2020 Oct;24(6-7):567-575. doi: 10.1016/j.canrad.2020.06.008. Epub 2020 Aug 16. Cancer Radiother. 2020. PMID: 32814669 Review. French.

7

[Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].

Bensouda Y, André F, Boulet T, Al-Ghuzlan A, Conforti R, Troalen F, Bourgier C, Errihani H, Spielmann M, Delaloge S. Bensouda Y, et al. Among authors: bourgier c. Bull Cancer. 2009 Oct;96(10):923-8. doi: 10.1684/bdc.2009.0919. Bull Cancer. 2009. PMID: 19696005 French.

8

Overview of preoperative radiochemotherapy in breast cancer: past or future?

Bourgier C, Calvo FA, Marsiglia H, Martín M. Bourgier C, et al. Clin Transl Oncol. 2011 Jul;13(7):446-50. doi: 10.1007/s12094-011-0681-2. Clin Transl Oncol. 2011. PMID: 21775271 Review.

9

Effect of preoperative rescue concomitant FUN/XUN-based chemo-radiotherapy for neoadjuvant chemotherapy-refractory breast cancer.

Bourgier C, Ghorbel I, Heymann S, Barhi M, Mazouni C, Al Ghuzlan AA, Balleyguier C, Marsiglia H, Delaloge S. Bourgier C, et al. Radiother Oncol. 2012 May;103(2):151-4. doi: 10.1016/j.radonc.2012.01.008. Epub 2012 Mar 6. Radiother Oncol. 2012. PMID: 22402230

10

Phase II trial of 3D-conformal accelerated partial breast irradiation: lessons learned from patients and physicians' evaluation.

Azoury F, Heymann S, Acevedo C, Spielmann M, Vielh P, Garbay JR, Taghian AG, Marsiglia H, Bourgier C. Azoury F, et al. Among authors: bourgier c. Radiother Oncol. 2012 May;103(2):193-8. doi: 10.1016/j.radonc.2012.03.019. Epub 2012 Apr 20. Radiother Oncol. 2012. PMID: 22521749 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters